Literature DB >> 6379961

Mechanism of the adjuvant effect of hemoglobin in experimental peritonitis: VIII. A leukotoxin is produced by Escherichia coli metabolism in hemoglobin.

T L Pruett, O D Rotstein, V D Fiegel, J J Sorenson, R D Nelson, R L Simmons.   

Abstract

Hemoglobin, but not albumin, has long been recognized as an infection potentiating factor in experimental Escherichia coli peritonitis, but the mechanism has defied definition. We have shown previously that stroma-free hemoglobin is not toxic to polymorphonuclear neutrophils. To test the hypothesis that hemoglobin provides a nutritional boost to the growth of E. coli in vivo, we inoculated E. coli into dialysis bags containing equivalent amounts of stroma-free hemoglobin or albumin. These bags were implanted into the peritoneal cavity of rats and at intervals the fluid was removed and the bacteria enumerated. This technique allows for intraperitoneal bacterial growth but eliminates the variables of lymphatic clearance and phagocytic ingestion. The growth rate of E. coli was the same irrespective of the nutritional supplement in the bag. Thus there is no experimental support for the notion that hemoglobin directly accelerates E. coli proliferation under in vivo conditions. To test the hypothesis that a leukocyte toxin may result from E. coli growth in hemoglobin, we exposed normal human neutrophils to the sterilized contents of the peritoneal dialysis bags. In vitro function of the neutrophils (viability, random migration, chemotaxis, phagocytosis, bacterial killing, and chemiluminescence) was significantly depressed by prior exposure to hemoglobin supernatants that had supported E. coli proliferation in vivo. Stroma-free hemoglobin had minimal adverse effects. Albumin supernatants that had supported E. coli proliferation in vivo had significantly less effect on neutrophil function even though the endotoxin levels were identical to the hemoglobin E. coli solutions. We must conclude that leukotoxins result from E. coli growth in solutions of pure hemoglobin. The data support the idea that the infection potentiating effect of hemoglobin in vivo is due to such leukotoxins.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6379961

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  8 in total

Review 1.  The critical role of iron in some clinical infections.

Authors:  J J Bullen; C G Ward; H J Rogers
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-08       Impact factor: 3.267

2.  Dissecting Oncogenic RAS Signaling in Melanoma Development in Genetically Engineered Zebrafish Models.

Authors:  Andrew P Badrock; Adam Hurlstone
Journal:  Methods Mol Biol       Date:  2021

3.  Hemoglobin toxicity in experimental bacterial peritonitis is due to production of reactive oxygen species.

Authors:  Y M Yoo; K M Kim; S S Kim; J A Han; H Z Lea; Y M Kim
Journal:  Clin Diagn Lab Immunol       Date:  1999-11

4.  Escherichia coli hemoglobin protease autotransporter contributes to synergistic abscess formation and heme-dependent growth of Bacteroides fragilis.

Authors:  Ben R Otto; Silvy J M van Dooren; Charles M Dozois; Joen Luirink; Bauke Oudega
Journal:  Infect Immun       Date:  2002-01       Impact factor: 3.441

5.  A soluble Bacteroides by-product impairs phagocytic killing of Escherichia coli by neutrophils.

Authors:  O D Rotstein; T Vittorini; J Kao; M I McBurney; P E Nasmith; S Grinstein
Journal:  Infect Immun       Date:  1989-03       Impact factor: 3.441

Review 6.  Epidemiology and pathophysiology of intraabdominal infections (IAI).

Authors:  E H Farthmann; U Schöffel
Journal:  Infection       Date:  1998 Sep-Oct       Impact factor: 3.553

7.  Effect of iron compounds on antibacterial function of human polymorphs and plasma.

Authors:  C G Ward; J S Hammond; J J Bullen
Journal:  Infect Immun       Date:  1986-03       Impact factor: 3.441

8.  Genetic alterations in the 3q26.31-32 locus confer an aggressive prostate cancer phenotype.

Authors:  Benjamin S Simpson; Niedzica Camacho; Hayley J Luxton; Hayley Pye; Ron Finn; Susan Heavey; Jason Pitt; Caroline M Moore; Hayley C Whitaker
Journal:  Commun Biol       Date:  2020-08-14
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.